Type 2 Diabetes Clinical Research Study

Medinova Research are looking for volunteers to take part in a research study to evaluate a new mealtime insulin to see if it can further improve blood sugar control in people with Type 2 diabetes.

The potential benefits of the new mealtime insulin include; induces less weight gain, reduces the frequency of hypoglycaemic episodes and Improvement in long term glucose control (HbA1c).

Qualifying participants will receive £180 (two payments of £90) during the course of the study. Travelling expenses and overnight accommodation reimbursement are also available. The study involves number of clinic visits and phone calls.

Participants will also receive all study related care, including ophthalmology checks and study medications at no cost.

Participating centres:

• London
  North London Clinical Studies Centre at Mount Vernon Hospital, HA6 2RN or South London Clinical Studies Centre at Queen Mary’s Hospital, Sidcup, DA14 6LT
• Hull
  Hull & East Yorkshire Hospitals Trust, Brocklehurst Building. Anlaby Road, Hull, HU3 2RW
• Wrexham
  Gladstone Centre Renal and Diabetes Unit, Croesnewydd Road, Wrexham Technology Park, Wreham, LL13 7TD
• Doncaster
  Haxey Branch Surgery, 30 Church Street, Haxey, Doncaster, DN9 2HY
• Northampton
  Research & Development Unit, Cliftonville, Northampton, NN1 5BD
• Northwood
  Mount Vermon Hospital, Rickmansworth Road, Northwood, Middlesex, HA6 2RN
• Stoke on Trent
  Research and Development Department, Academic Research Unit, B Block 1st Floor, Newcastle Road, Stoke on Trent, ST4 6QG
• Nuneaton
  Diabetes Centre, College Street, Nuneaton, Warwickshire, CV10 7DJ
• Norwich
  Diabetes Research, Clinical Research & trial Units, Norwich Medical, University of East Anglia, Norwich, NR4 7TJ

To join the trial, you must:

• Be aged 18 years or older
• Have Type 2 diabetes
• Be on insulin for at least 6 months, basal or long acting insulins; Levemir (Insulin detemir), Lantus (Insulin glargine), Humulin I, Insulatard and Insuman Basal
• Currently be taking metformin at least 1000mg / day

You will not be eligible for the trial if:

• You have had a heart attack, heart surgery or stroke in the last 6 months
• You are on any of the following medications: Forxiga (Dapagliflozin), Actos (Pioglitazone), Bydureon;  Byetta  (Exenatide), Victoza (Liraglutide)
• You are on any of the following short acting insulins: Apidra, Humalog, NovoRapid, Actrapid, Humulin,  Humulin S, Humulin M3, Insuman Rapid, Insuman Comb, Novomix 30, Humalog Mix 25